The overall goal of this proposal is to acquire funds to purchase a Q Exactive Plus LC-MS/MS System to replace a decade old Agilent 6520 Quadrupole ? Time-of-Flight (Q-TOF) mass spectrometer with an Agilent 1260 HPLC system. The funds will be used to purchase a Q Exactive Plus coupled with a UPLC chromatographic system that will be dedicated to support NIH-funded investigators requiring metabolomics analysis. Our well-established Metabolomics Program is part of The Johns Hopkins Institute for Clinical and Translational Research (ICTR) -supported program and The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center (JHU SKCCC) which has been an NCI- Designated Comprehensive Cancer Center since 1976. The ICTR (established in 2007), provides the bridge to overcome obstacles in translating basic science discoveries into clinical research and uses; connecting research discoveries and clinical practice. The ICTR provides a wide range of services within five coordinated Cores. The JHU SKCCC is a Cancer Center shared resource that provides funded investigators with technical expertise and access to large equipment for quantitative analysis of endogenous and exogenous metabolites. The Metabolomics Program has been extensively used by NIH-funded investigators from several Johns Hopkins campuses (main medical campus, Bayview medical campus, Applied Physics Laboratory and JHU Homewood campus) who are conducting clinical trials in cancer patients with promising new therapies, in aging, in health effects of air pollution and in many other health problems. The Metabolomics Program also supports preclinical research projects. The rapid growth in requirement of metabolomics analysis in cancer metabolism research and studies of metabolic aspects of other diseases requires a robust metabolomics platform as an invaluable tool for gaining insights into several biochemical processes of human diseases. In this proposal, four established and qualifying NIH-funded investigators are joined by 6 other funded investigators to focus research efforts on the treatment and prevention of major health problems. With the right instrument, the depth of the PIs' expertise in cancer metabolism and metabolomics technologies, in collaboration with other experts at Johns Hopkins, will lead to improved outcomes for human disease therapy.

Public Health Relevance

The requested Q Exactive Plus Orbitrap LC?MS/MS System is needed to support the NIH?funded research of scientists who are working to develop new metabolite markers and treatments for several essential aspects of human health (cancer, aging, genetic, cardiovascular, toxicology?). The ability to quantify metabolites in cells, plasma, and tissues with high sensitivity and specificity provided by the requested instrument is an essential need of research projects that aims to improve the therapy of diseases or to understand the basic mechanisms of biological processes. The availability of this instrument will greatly facilitate not only studies in the laboratory but also clinical trials in patients.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
1S10OD025226-01
Application #
9493744
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Horska, Alena
Project Start
2018-08-01
Project End
2019-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Pathology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Park, Joshua K; Coffey, Nathan J; Limoges, Aaron et al. (2018) The Heterogeneity of Lipid Metabolism in Cancer. Adv Exp Med Biol 1063:33-55
Camelo, Felipe; Le, Anne (2018) The Intricate Metabolism of Pancreatic Cancers. Adv Exp Med Biol 1063:73-81
Jung, Jin G; Le, Anne (2018) Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts. Adv Exp Med Biol 1063:167-178
Nguyen, Tu; Le, Anne (2018) The Metabolism of Renal Cell Carcinomas and Liver Cancer. Adv Exp Med Biol 1063:107-118
Quinones, Addison; Le, Anne (2018) The Multifaceted Metabolism of Glioblastoma. Adv Exp Med Biol 1063:59-72
Antonio, Marjorie Justine; Le, Anne (2018) Different Tumor Microenvironments Lead to Different Metabolic Phenotypes. Adv Exp Med Biol 1063:119-129
Kirsch, Brian James; Chang, Shu-Jyuan; Le, Anne (2018) Non-Hodgkin Lymphoma Metabolism. Adv Exp Med Biol 1063:95-106
Tan, Jessica; Le, Anne (2018) Breast Cancer Metabolism. Adv Exp Med Biol 1063:83-93
Bose, Sminu; Le, Anne (2018) Glucose Metabolism in Cancer. Adv Exp Med Biol 1063:3-12
Nabi, Karim; Le, Anne (2018) The Intratumoral Heterogeneity of Cancer Metabolism. Adv Exp Med Biol 1063:131-145